We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$20.1B
AUM Growth
+$951M
Cap. Flow
-$224M
Cap. Flow %
-1.12%
Top 10 Hldgs %
32.44%
Holding
721
New
63
Increased
299
Reduced
261
Closed
36

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$55.1M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$46.1M
3
BABA icon
Alibaba
BABA
+$45M
4
NEE icon
NextEra Energy
NEE
+$40.9M
5
AMZN icon
Amazon
AMZN
+$38.3M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$50.3M
2
META icon
Meta Platforms (Facebook)
META
+$44.2M
3
PG icon
Procter & Gamble
PG
+$34.1M
4
ZTS icon
Zoetis
ZTS
+$33.6M
5
CAH icon
Cardinal Health
CAH
+$32.2M

Sector Composition

Rank Sector Weight
1 Technology 34.01%
2 Healthcare 26.73%
3 Financials 11.13%
4 Consumer Discretionary 7.93%
5 Communication Services 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALL icon
151
Allstate
ALL
$69.3B
$28.1M 0.14%
134,780
-14,311
-10% -$2.93M
DXCM icon
152
DexCom
DXCM
$29.2B
$27.8M 0.14%
418,460
+174,097
+71% +$11.3M
BMO icon
153
Bank of Montreal
BMO
$126B
$27.2M 0.14%
209,417
+28,854
+16% +$3.65M
PWR icon
154
Quanta Services
PWR
$88.1B
$27.1M 0.14%
64,221
+2,860
+5% +$1.26M
WDC icon
155
Western Digital
WDC
$158B
$26.9M 0.13%
156,309
-189,832
-55% -$28.8M
JBL icon
156
Jabil
JBL
$31.4B
$26.8M 0.13%
117,635
-4,250
-3% -$907K
KLAC icon
157
KLA
KLAC
$251B
$26.8M 0.13%
220,360
+3,880
+2% +$455K
TPR icon
158
Tapestry
TPR
$30.3B
$26.8M 0.13%
209,479
-19,233
-8% -$2.2M
CBRE icon
159
CBRE Group
CBRE
$43.5B
$26.6M 0.13%
165,193
+6,513
+4% +$1.02M
FIX icon
160
Comfort Systems
FIX
$56.8B
$26.4M 0.13%
28,286
+27,764
+5,319% +$25.6M
MFC icon
161
Manulife Financial
MFC
$74.2B
$26M 0.13%
716,046
+4,512
+0.6% +$153K
BRKR icon
162
Bruker
BRKR
$9.48B
$25.8M 0.13%
547,603
+45,924
+9% +$1.94M
BMA icon
163
Banco Macro
BMA
$5.83B
$25.6M 0.13%
283,920
-38,680
-12% -$2.92M
IAG icon
164
IAMGOLD
IAG
$8.31B
$25.4M 0.13%
1,540,000
-520,000
-25% -$7.33M
PEP icon
165
PepsiCo
PEP
$194B
$25.3M 0.13%
176,355
-129,254
-42% -$19M
MDLZ icon
166
Mondelez International
MDLZ
$80B
$24.7M 0.12%
458,248
-130,169
-22% -$7.49M
MLYS icon
167
Mineralys Therapeutics
MLYS
$2.37B
$24.6M 0.12%
678,387
+110,606
+19% +$4.44M
VRDN icon
168
Viridian Therapeutics
VRDN
$2.16B
$24.4M 0.12%
785,098
-75,134
-9% -$2.06M
BMRN icon
169
BioMarin Pharmaceuticals
BMRN
$12B
$24.3M 0.12%
408,426
-134,338
-25% -$7.31M
APP icon
170
Applovin
APP
$141B
$24.2M 0.12%
35,921
+1,596
+5% +$1.01M
HLT icon
171
Hilton Worldwide
HLT
$73.3B
$24.1M 0.12%
83,989
+10,166
+14% +$2.77M
CHE icon
172
Chemed
CHE
$6.84B
$24.1M 0.12%
56,231
+13,175
+31% +$5.74M
CCK icon
173
Crown Holdings
CCK
$13.1B
$23.5M 0.12%
228,207
-89,356
-28% -$8.71M
FTNT icon
174
Fortinet
FTNT
$111B
$23.4M 0.12%
294,476
-15,687
-5% -$1.3M
ARQT icon
175
Arcutis Biotherapeutics
ARQT
$3.54B
$23.3M 0.12%
803,138
+25,094
+3% +$642K

Similar funds

Candriam SCA's Q4 2025 Portfolio in Review

As of Q4 2025, Candriam SCA held 721 positions worth $20.1B, up 5% from $19.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q4 2025 filing shows 63 new, 299 increased, 261 reduced and 36 closed positions. Its largest new stake was Alibaba: 276,080 shares worth $40.5M. The largest sale was Equinix, an estimated $50.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2025 buy was Alibaba: 276,080 shares worth $40.5M.
  • Candriam SCA added most to AbbVie in Q4 2025, an estimated $55.1M increase.
  • Candriam SCA's biggest Q4 2025 reduction was Equinix, cutting an estimated $50.3M.
  • Candriam SCA fully exited Universal Display in Q4 2025, selling an estimated $27.1M.
  • Candriam SCA's ten largest holdings make up 32% of its $20.1B portfolio in Q4 2025.
  • Candriam SCA opened 63 new positions and closed 36 in Q4 2025.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $20.1B.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.